Press "Enter" to skip to content

New patent expiration for Abraxis Bioscience drug ABRAXANE

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Abraxis Bioscience drug ABRAXANE

Annual Drug Patent Expirations for ABRAXANE
Annual Drug Patent Expirations for ABRAXANE

Abraxane is a drug marketed by Abraxis Bioscience and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for ABRAXANE.

The generic ingredient in ABRAXANE is paclitaxel. One supplier is listed for this compound. Additional details are available on the paclitaxel profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Abraxis Bioscience drug ABRAXANE
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions